Loading briefing details...
News Abstract
By: PointLine Media Research & Editorial Team
June 2, 2026
New Horizon Medical Solutions (NHMS) has announced the promotion of Raymond Jessen, MPH, MHSA, CTBS, to Senior Vice President of Compliance, Regulatory Affairs & Quality.
This appointment acknowledges Jessen's significant contributions to establishing NHMS's compliance framework and advancing regulatory strategies for medical devices and human cells, tissues, and cellular and tissue-based products (HCT/Ps).
In his expanded capacity, Jessen will be responsible for overseeing regulatory strategy, the quality management system, and the overall compliance infrastructure. This includes ensuring inspection readiness, managing product lifecycle planning, and mitigating risks.
Jessen brings over 25 years of experience from various healthcare organizations, with a proven history of managing thousands of regulatory submissions across medical devices, HCT/Ps, and pharmaceutical products.
The medical solutions industry operates under rigorous regulatory oversight, demanding precise compliance and robust quality assurance. For companies like New Horizon Medical Solutions, specializing in advanced wound care and biologically derived products, navigating complex regulatory landscapes from bodies such as the FDA and CMS is paramount.
Elevating experienced professionals in compliance and quality leadership roles reflects a strategic industry imperative. Such promotions help ensure patient safety, mitigate significant enterprise risks, and streamline market access for new therapies, aligning with a broader trend of integrating stringent oversight into every operational aspect to meet evolving standards and maintain public trust.